Johnson & Johnson developed a new single-dose COVID-19 vaccine and is seeking emergency FDA authorization. The new vaccine requires less care versus currently available vaccines, making distribution easier.

We are still in the grip of COVID, but with the aid of vaccines and continued health measures we will beat the disease.